Bacillus Calmette Guérin in bladder cancer: is more immune stimulation better?
- PMID: 32042636
- PMCID: PMC6989848
- DOI: 10.21037/tau.2019.12.23
Bacillus Calmette Guérin in bladder cancer: is more immune stimulation better?
Conflict of interest statement
Conflicts of Interest: The author has no conflicts of interest to declare.
Comment on
-
In vitro Evidence of Human Immune Responsiveness Shows the Improved Potential of a Recombinant BCG Strain for Bladder Cancer Treatment.Front Immunol. 2019 Jun 26;10:1460. doi: 10.3389/fimmu.2019.01460. eCollection 2019. Front Immunol. 2019. PMID: 31297119 Free PMC article.
Similar articles
-
Anti-interleukin-10R1 monoclonal antibody enhances bacillus Calmette-Guérin induced T-helper type 1 immune responses and antitumor immunity in a mouse orthotopic model of bladder cancer.J Urol. 2012 Jun;187(6):2228-35. doi: 10.1016/j.juro.2012.01.030. Epub 2012 Apr 13. J Urol. 2012. PMID: 22503050
-
Emerging Immunotherapy Options for bacillus Calmette-Guérin Unresponsive Nonmuscle Invasive Bladder Cancer.J Urol. 2019 Dec;202(6):1111-1119. doi: 10.1097/JU.0000000000000297. Epub 2019 May 1. J Urol. 2019. PMID: 31042108 Review.
-
Construction of predictive models for cancer-specific survival of patients with non-muscle-invasive bladder cancer treated with bacillus Calmette-Guérin: results from a multicenter retrospective study.Jpn J Clin Oncol. 2014 Nov;44(11):1101-8. doi: 10.1093/jjco/hyu119. Epub 2014 Aug 19. Jpn J Clin Oncol. 2014. PMID: 25139163
-
FGFR3 Down-Regulation is Involved in bacillus Calmette-Guérin Induced Bladder Tumor Growth Inhibition.J Urol. 2016 Jan;195(1):188-97. doi: 10.1016/j.juro.2015.06.093. Epub 2015 Jul 2. J Urol. 2016. PMID: 26144336
-
Intravesical Therapy for the Treatment of Nonmuscle Invasive Bladder Cancer: A Systematic Review and Meta-Analysis.J Urol. 2017 May;197(5):1189-1199. doi: 10.1016/j.juro.2016.12.090. Epub 2016 Dec 24. J Urol. 2017. PMID: 28027868
References
Publication types
LinkOut - more resources
Full Text Sources